What Does That Mean For Me?

An excerpt from a study on clinical endocannabinoid deficiencies reads: “Medicine continues to struggle in its approaches to numerous common subjective pain syndromes that lack objective signs and remain treatment-resistant. Foremost among these are migraine, fibromyalgia, and irritable bowel syndrome, disorders that may overlap in their affected populations and whose sufferers have all endured the stigma of a psychosomatic label, as well as the failure of endless pharmacotherapeutic interventions with substandard benefit. The commonality in symptomatology in these conditions displaying hyperalgesia and central sensitization with possible common underlying pathophysiology suggests that a clinical endocannabinoid deficiency might characterize their origin.” In short, this study suggests many of our more mysterious conditions today might be linked to a simple CBD deficiency. 

Clinical Endocannabinoid Deficiency (CECD) occurs when an individual produces fewer cannabinoids than experts consider to be essential in the maintenance of health & wellness.

Luckily, supplementing with CBD is safer, easier, and more accessible than ever. It’s 100% legal to supplement with CBD and it can be found at your local pharmacies and retailers or online for your convenience.

From us at Elixinol, we personally recommend our strongest impacting CBD – formulated to be water-soluble, making it 7 times more effective than oily tinctures: Liposomal. It’s also 30 times more effective than CBD isolates, making it the informed decision & purchase for any new cannabis shopper. If you’d like some one-on-one guidance, get in touch with our team of experts from one of the world’s best CBD brands – we’ll get back to your messages via social media or emails within a few hours. You can also pick up the phone and speak with us directly, we’re happy to be of assistance and help you make the right choice on your CBD journey.